Latest advances in clinical studies of circulating tumor cells in early and metastatic breast cancer
Author:
Publisher
Elsevier
Reference66 articles.
1. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis;Aceto;Cell,2014
2. Circulating tumor cells and response to neoadjuvant paclitaxel and HER2-targeted therapy: A sub-study from the NeoALTTO phase III trial;Azim;Breast,2013
3. Potential role of circulating tumor cell detection and monitoring in breast cancer: A review of current evidence;Banys-Paluchowski;Frontiers in Oncology,2016
4. Prognostic impact of HER2 and ER status of circulating tumor cells in metastatic breast cancer patients with a HER2-negative primary tumor;Beije;Neoplasia (New York, N. Y.),2016
5. Efficacy of circulating tumor cell count-driven vs clinician-driven first-line therapy choice in hormone receptor-positive, ERBB2-negative metastatic breast cancer: The STIC CTC randomized clinical trial;Bidard;JAMA Oncology,2021
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Circulating Tumor Cells: Pathological, Molecular and Functional Characteristics;International Journal of Molecular Sciences;2024-07-27
2. Longitudinal analysis of circulating tumor cell numbers improves tracking metastatic breast cancer progression;Scientific Reports;2024-06-05
3. Exploring the Immunological Profile in Breast Cancer: Recent Advances in Diagnosis and Prognosis through Circulating Tumor Cells;International Journal of Molecular Sciences;2024-04-29
4. Think “HER2” different: integrative diagnostic approaches for HER2-low breast cancer;Pathologica;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3